NEW YORK— Medical device maker Abbott Laboratories said Thursday it has agreed to buy replacement heart valve maker Tendyne Holdings for $225 million, and has invested in a second company in the field. Tendyne is conducting a U.S. clinical trial of a product called the bioprosthetic mitral valve system and it plans to start a study in 2016 to support approval of...» Read More
The government is making an increasing number of expensive life-saving or life extending drugs and devices available to more people, but is that the right thing to do and can we afford it, anyway?
Health care is an emotional subject for many Americans — and often one of extremes. Yet, as we obssess about the system's structure and cost, we neglect our own health. Obesity and high blood pressure are more common, while exercise and diet are overlooked. Our special report, "Healthy Business", explores these issues.
More and more American women are seeking infertility treatment to increase their chances of having a child, but there's been no change in success rates and costs remain high, even with health insurance coverage.
Expected government cuts to Medicare and Medicaid, the uncertainty of health care reform and looming patent expirations are weighing heavily on the outlook of the biggest companies in the sector: large-cap pharmaceutical stocks.
Among the crowded ranks of healthy food trends -- quinoa, farm-to-table, whole whole grains — one food category is growing into a genuine, industry juggernaut: gluten-free.
Health-conscious U.S. consumers are buying hundreds of millions of dollars of so-called superfruits annually, even as critics contend their nutritional benefits are overblown and, in some cases, nonexistent.
The Centers for Disease Control considers obesity in America an epidemic; more than one out of three adults and 17 percent of all children are technically overweight to the point of obesity.
American spends more on health care than any other country. Do you know where it goes?
The "Fast Money" traders discuss the market movers that caught their eye this week.
Over the last 20 years, Americans have witnessed unprecedented advances in care of hospitalized patients. Improved diagnostic procedures, quantum leaps in medical technology, enhanced treatments and a public now familiar with the concept of preventative medical care all mean that healthcare – especially in the hospital – has changed to meet the health care needs of today’s patients.
Finding Qatar on a map may be as difficult as learning how to pronounce the country's name. But analysts say that shouldn't stop investors from targeting the small desert nation—as long as they understand the business culture .
With stocks shrugging off the wall of worry in the first quarter, the second quarter could prove to be a less rewarding time for those long equity markets as central banks begin to tighten policy via rate hikes or withdrawing extraordinary measures.
A selloff may be likely ahead of the end to the Fed's QE2, growth outside the U.S. will lead and technological in health care will attract investors.
Cramer thinks this is it. Check out his interview with this company's CEO.
Telemedicine has attracted major investments from some of the nation's largest companies over the past year. And it has been endorsed by doctors and care takers who believe patients fare better at home.
Why this particular group is hot right now and how Cramer recommends trading it.